Johnson & Johnson vs. Wave Life Sciences Ltd. Ordinary Shares
Johnson & Johnson (JNJ) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| JNJ | WVE | |
|---|---|---|
| Market Cap | $653.61 billion | $744.84 million |
| Revenue (TTM) | $97.93 billion | $65.37 million |
| Net Income (TTM) | $21.04 billion | $-202,473,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | WVE | |
|---|---|---|
| P/E Ratio | 31.46 | — |
| Price / Book | 7.69 | 1.64 |
| Price / Sales | 6.67 | 11.39 |
JNJ and WVE split the valuation factors evenly.
Profitability
| JNJ | WVE | |
|---|---|---|
| Net Margin | 21.48% | -309.73% |
| Return on Equity | 24.76% | -44.64% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| JNJ | WVE | |
|---|---|---|
| Dividend Yield | 1.98% | — |
| Payout Ratio | 62.18 | — |
JNJ and WVE split the dividend factors evenly.
Risk & Sentiment
| JNJ | WVE | |
|---|---|---|
| Short Interest | 0.67% | 1.22% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, WVE overview, WVE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.